AEGON Asset Management (UK)’s Bristol-Myers Squibb BMY Stock Holding History

AEGON Asset Management (UK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.6M	Sell	635,252 -562,947	-47%	-$32.3M	0.39%	58
2026 Q1	$72.7M	Buy	1,198,199 +587,520	+96%	+$34.2M	0.96%	27
2025 Q4	$32.9M	Buy	610,679 +408,133	+202%	+$19.6M	0.39%	70
2025 Q3	$9.13M	Hold	202,546	–	–	0.11%	124
2025 Q2	$9.37M	Sell	202,546 -25,858	-11%	-$1.27M	0.12%	117
2025 Q1	$13.9M	Buy	228,404 +3,139	+1%	+$183K	0.2%	105
2024 Q4	$12.7M	Sell	225,265 -29,605	-12%	-$1.65M	0.17%	111
2024 Q3	$13.2M	Sell	254,870 -56,106	-18%	-$2.63M	0.18%	115
2024 Q2	$12.9M	Hold	310,976	–	–	0.18%	113
2024 Q1	$16.9M	Sell	310,976 -56,522	-15%	-$2.88M	0.25%	71
2023 Q4	$18.8M	Buy	+367,498	New	+$19.3M	0.3%	73
2023 Q2	$28.4M	Sell	443,397 -655,371	-60%	-$43.9M	0.46%	59
2023 Q1	$76.1M	Sell	1,098,768 -13,332	-1%	-$940K	1.33%	18
2022 Q4	$80M	Buy	1,112,100 +8,334	+0.8%	+$628K	1.45%	18
2022 Q3	$78.5M	Buy	1,103,766 +277,717	+34%	+$20.1M	1.59%	16
2022 Q2	$63.7M	Buy	+826,049	New	+$62.9M	1.2%	23
2020 Q3	–	Sell	-53,749	Closed	-$3.16M	–	148
2020 Q2	$3.16M	Hold	53,749	–	–	0.07%	97
2020 Q1	$2.99M	Buy	53,749 +6,670	+14%	+$408K	0.09%	89
2019 Q4	$3.02M	Hold	47,079	–	–	0.07%	103
2019 Q3	$2.39M	Hold	47,079	–	–	0.06%	113
2019 Q2	$2.13M	Buy	+47,079	New	+$2.19M	0.06%	112
2018 Q4	–	Sell	-3,693	Closed	-$229K	–	167
2018 Q3	$229K	Buy	+3,693	New	+$219K	0.01%	181

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AEGON Asset Management (UK)'s BMY Position: Q2 2026 in Review

AEGON Asset Management (UK) reduced its Bristol-Myers Squibb (BMY) stake by 47% in Q2 2026, selling an estimated $32.3M and leaving 635,252 shares worth $36.6M. The position accounts for 0.39% of the portfolio, ranked #58.

AEGON Asset Management (UK) first reported a position in BMY in Q3 2018 and has held it in 22 quarters since. The position peaked at $80M in Q4 2022. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

AEGON Asset Management (UK) held 635,252 shares of Bristol-Myers Squibb worth $36.6M as of Q2 2026.
AEGON Asset Management (UK) sold 562,947 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.3M.
Bristol-Myers Squibb made up 0.39% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #58 holding.
AEGON Asset Management (UK) first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 22 quarters since.
AEGON Asset Management (UK)'s Bristol-Myers Squibb position peaked at $80M in Q4 2022.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.